HAL (France)open access
Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis
Non-steroidal mineralocorticoid receptor antagonists, Cardio-oncology, Cancer, 0, Cardio-kidney-metabolic, Malignancy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 624729
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.